✦ LIBER ✦

Response to interferon-beta therapy in relapsing–remitting multiple sclerosis: a comparison of different clinical criteria

✍ Scribed by Portaccio, E; Zipoli, V; Siracusa, G; Sorbi, S; Amato, MP

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical significance of antibodies to i

✍ Klaus Bendtzen 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Predictors of long–term clinical respons

✍ V. Tomassini; A. Paolillo; P. Russo; E. Giugni; L. Prosperini; C. Gasperini; G. 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 261 KB

A phase I clinical trial of human recomb

✍ J.I. Greenstein; R.L. Knobler; K.P. Johnson; S.G. Marcus; H.S. Panitch; F.D. Lub 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Comparison of interferon beta products a

✍ M. Etemadifar; M. Janghorbani; V. Shaygannejad 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 264 KB

Outcome of beta-interferon treatment in

✍ K. O'Rourke; C. Walsh; M. Hutchinson 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 296 KB

Clinical importance of neutralising anti

✍ Per Soelberg Sorensen; Christian Ross; Katja Maria Clemmesen; Klaus Bendtzen; Je 📂 Article 📅 2003 🏛 The Lancet 🌐 English ⚖ 129 KB